TABLE 2.
Comparison of titers 1/2 or 1 dilution greater in endpoint of frozen banked sera from undocumented and documented cases of syphilis, tested with CDC synthetic VDRL antigen and with CDC and BDMS reference VDRL antigens
Syphilis category | No. of specimens
|
|||
---|---|---|---|---|
Total | With CDC synthetic VDRL antigen higher | With natural VDRLa antigen higher | With CDC synthetic and natural VDRL antigen endpoints equal | |
Undocumented | 100 | 85 | 0 | 15 |
Documented | ||||
Untreated | ||||
Primary | 9b | 3 | 2 | 4 |
Secondary | 20 | 20 | 0 | 0 |
Latent | 6c | 4 | 0 | 1 |
Treated | ||||
Primary | 15d | 10 | 0 | 2 |
Secondary | 30 | 30 | 0 | 0 |
Latent | 20e | 17 | 1 | 0 |
Total | 200 | 169 | 3 | 7 |
Natural VDRL antigen was either CDC reference VDRL (undocumented serum samples) or BDMS VDRL antigen (documented sera).
One sample was nonreactive with TP-PA but reactive with both VDRL antigens.
One sample was reactive with TP-PA but nonreactive with both VDRL antigens.
One sample was reactive with TP-PA but nonreactive with both VDRL antigens, and two samples were nonreactive with TP-PA and both VDRL antigens.
One sample was reactive with TP-PA but nonreactive with both VDRL antigens, and one sample was nonreactive with TP-PA and both VDRL antigens.